Paris-based European venture capital company Truffle Capital closed its €250m BioMedTech fund – celebrating...
Up To Date
Latest News
Basel-based biopharma company Cellestia Biotech AG has successfully closed a Series B financing round, raising...
Data from 1,200 heart failure patients demonstrate that high discharge levels of the biomarker bio-ADM®...
The new company, named Augustine Therapeutics, is a Vlaams Instituut voor Biotechnologie (VIB) and Katholieke...
French Transgene SA said it has terminated its lead programme TG4010 in combination with chemotherapy and...
New research demonstrates that disruption of EGF receptor signalling allows commensal bacteria to invade...